| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.0095 | 0.9 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.009 | 0.9 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.025 | 0.9 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |